Select committee: Women and Equalities Committee
Recommendation 15
Fifth Report - The prevalence of sexually transmitted infections in young people and other high risk groups
Published 26 Mar 2024
Paragraph 65
Addressed to Government Equalities Office
Women and Equalities Committee Prevalence of STIs among young people All items in this report Report on parliament.uk ↗ Inquiry on parliament.uk ↗
Recommendation (the committee's words)
In light of the increases in chlamydia diagnoses, the Government should review whether the shift in focus of the National Chlamydia Screening Programme to restricting the offer of opportunistic screening to young women has been effective.
From: Women and Equalities Committee, Fifth Report - The prevalence of sexually transmitted infections in young people and other high risk groups (HC 463), paragraph 65, 26 March 2024
Government response
The government responded to the whole report on 7 May 2025 (deadline 26 May 2024).
Summary written by Accountability Index from the government's response. It is not the government's own words.The government's response to the Committee's recommendations is mixed: it accepts some, partially accepts most, and gives its reasons and commitments for each.
- On the public health grant, the government "partially accepts" the call for a radical increase, noting a 2025/26 rise to £3.858 billion and that, "Subject to the spending review", it "will aim to issue multi-year allocations from 2026/27 onwards".
- On assessing repeated tendering, it "partially accepts" the recommendation but says "no further assessment is planned at this stage", citing the Provider Selection Regime introduced on 1 January 2024.
- On a national sexual health strategy, it "partially accepts" the recommendation and points to a new HIV Action Plan, which it "aim[s] to publish in 2025", including an objective to stabilise and support the wider sexual and reproductive health system.
- It "accepts" the recommendations on antibiotic development, condom promotion, prevention campaigns and the chlamydia screening review, though on the last it says "insufficient time has elapsed" to evaluate any impact of the policy change.